[HTML][HTML] Synergy of brief activation of CD8 T-cells in the presence of IL-12 and adoptive transfer into lymphopenic hosts promotes tumor clearance and anti-tumor …

CM Díaz-Montero, O Naga, AAA Zidan… - American journal of …, 2011 - ncbi.nlm.nih.gov
CM Díaz-Montero, O Naga, AAA Zidan, ML Salem, M Pallin, A Parmigiani, G Walker…
American journal of cancer research, 2011ncbi.nlm.nih.gov
Adoptive T-cell therapy holds great promise for the treatment of metastatic melanoma.
However, prohibitive costs associated with current technology required for culture and
expansion of tumor-reactive T-cells, the need for intense preconditioning regimens to induce
lymphopenia, and the unpredictable anti-tumor effect of adoptively transferred T-cells remain
significant impediments for its clinical implementation. Here we report a simplified
combinatorial approach that involves short activation of CD8+ T cells in the presence of IL …
Abstract
Adoptive T-cell therapy holds great promise for the treatment of metastatic melanoma. However, prohibitive costs associated with current technology required for culture and expansion of tumor-reactive T-cells, the need for intense preconditioning regimens to induce lymphopenia, and the unpredictable anti-tumor effect of adoptively transferred T-cells remain significant impediments for its clinical implementation. Here we report a simplified combinatorial approach that involves short activation of CD8+ T cells in the presence of IL-12 followed by adoptive transfer into tumor bearing animals after a single injection of cyclophosphamide. This approach resulted in complete eradication of B16 melanoma, and the establishment of long term immunological memory capable of fully protecting mice after a second B16 melanoma challenge. The activated donor cells were unique because they simultaneously exhibited traits for cytotoxic effector function, central memory-like, homing, and senescence. After tumor eradication and within three months after transfer, CD8+ cells exhibited a conventional memory CTL phenotype. Moreover, these memory CTLs acquired functional attributes characteristic of memory stem cells, including the ability to resist chemotherapy-induced toxicity. Our results suggest that short-term T-cell receptor signaling in the presence of IL-12 promotes promiscuous qualities in naïve CTL which-upon transfer into lymphopenic hosts-are sufficient to eradicate tumors and generate life-long tumor-specific memory.
ncbi.nlm.nih.gov